News Focus
News Focus
icon url

Work Harder

04/22/21 5:56 PM

#24446 RE: Work Harder #24445

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody

https://authors.library.caltech.edu/101003/

Check out the Additional Information:

Jesse D. Bloom

5 Basic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA

14 Howard Hughes Medical Institute, Seattle, WA 98109, USA

Rogier W. Sanders

7 Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands

8 Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA

Funding Agency Grant Number

Helmholtz Centre for Infection Research UNSPECIFIED

German Research Foundation (DFG)

https://www.dfg.de/en/dfg_profile/mission/what_is_the_dfg/index.html

https://www.dfg.de/en/

Collection: Caltech AUTHORS

https://www.sciencedirect.com/science/article/pii/S009286742030057X#!

Is Tamara C Stegmann connected to Rogier W Sanders
icon url

Work Harder

04/22/21 8:40 PM

#24452 RE: Work Harder #24445

This work, in collaboration with Pr. Rogier W. Sanders and Dr Marit van Gils of University Medical Centers in Amsterdam (Amsterdam UMC), demonstrated the efficacy of therapeutic NAbs rapidly developed for COVID-19 and its variants.

https://angany.com/angany-canada-france-and-phylloceuticals-usa-two-biotechnology-innovators-team-up-to-accelerate-covid-nabs-commercialization/

https://phylloceuticals.com/